Goldman Sachs
MIST icon

Goldman Sachs’s Milestone Pharmaceuticals MIST Stock Holding History

Goldman Sachs’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.38M Buy
+2,000,025
New +$3.5M ﹤0.01% 4381
2025
Q4 		– Sell
-356,567
Closed -$713K – 6680
2025
Q3 		$713K Buy
356,567
+237,118
+199% +$417K ﹤0.01% 5280
2025
Q2 		$232K Buy
+119,449
New +$159K ﹤0.01% 5585
2025
Q1 		– Sell
-942,407
Closed -$2.22M – 6291
2024
Q4 		$2.22M Sell
942,407
-410,660
-30% -$705K ﹤0.01% 4185
2024
Q3 		$2.06M Hold
1,353,067
– – ﹤0.01% 4130
2024
Q2 		$1.79M Hold
1,353,067
– – ﹤0.01% 4006
2024
Q1 		$2.42M Hold
1,353,067
– – ﹤0.01% 3729
2023
Q4 		$2.26M Sell
1,353,067
-1,205,657
-47% -$3.27M ﹤0.01% 3828
2023
Q3 		$7.93M Buy
2,558,724
+3,437
+0.1% +$10.7K ﹤0.01% 2588
2023
Q2 		$7.28M Buy
2,555,287
+2,822
+0.1% +$10.6K ﹤0.01% 2763
2023
Q1 		$10.1M Sell
2,552,465
-94,651
-4% -$346K ﹤0.01% 2414
2022
Q4 		$10.5M Buy
2,647,116
+2,542,619
+2,433% +$13.4M ﹤0.01% 2538
2022
Q3 		$960K Buy
104,497
+92,493
+771% +$702K ﹤0.01% 4541
2022
Q2 		$74K Hold
12,004
– – ﹤0.01% 5941
2022
Q1 		$77K Hold
12,004
– – ﹤0.01% 6179
2021
Q4 		$79K Hold
12,004
– – ﹤0.01% 6184
2021
Q3 		$69K Hold
12,004
– – ﹤0.01% 5985
2021
Q2 		$66K Hold
12,004
– – ﹤0.01% 6035
2021
Q1 		$70K Sell
12,004
-10,246
-46% -$75K ﹤0.01% 5899
2020
Q4 		$149K Buy
22,250
+10,246
+85% +$68.6K ﹤0.01% 5186
2020
Q3 		$88K Buy
+12,004
New +$86K ﹤0.01% 5110

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Goldman Sachs's MIST Position: Q1 2026 in Review

Goldman Sachs opened a new position in Milestone Pharmaceuticals (MIST) in Q1 2026: 2,000,025 shares worth $2.38M. The stake represents ﹤0.01% of the portfolio and ranks #4381 among its holdings. This is a return to the name: Goldman Sachs previously reported a position in MIST as recently as Q3 2025.

Goldman Sachs first reported a position in MIST in Q3 2020 and has held it in 21 quarters since. The position peaked at $10.5M in Q4 2022. 86 funds tracked by Wall St. Rank hold MIST as of Q1 2026.

  • Goldman Sachs held 2,000,025 shares of Milestone Pharmaceuticals worth $2.38M as of Q1 2026.
  • Milestone Pharmaceuticals was a new Goldman Sachs position in Q1 2026.
  • Milestone Pharmaceuticals made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4381 holding.
  • Goldman Sachs first reported a position in Milestone Pharmaceuticals in Q3 2020 and has held it in 21 quarters since.
  • Goldman Sachs's Milestone Pharmaceuticals position peaked at $10.5M in Q4 2022.
  • 86 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.